<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01566318</url>
  </required_header>
  <id_info>
    <org_study_id>P30MH090333-PRC1</org_study_id>
    <secondary_id>P30MH090333</secondary_id>
    <nct_id>NCT01566318</nct_id>
  </id_info>
  <brief_title>Depression Agency-Based Collaboration</brief_title>
  <official_title>Depression Agency-Based Collaborative (Depression ABC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Seniors who receive supportive services face a variety of psychosocial vulnerabilities that&#xD;
      put them at risk for depression. One group with very high risk is older adults receiving&#xD;
      aging services through Medicaid waiver programs. This 3-year research uses a randomized&#xD;
      controlled clinical trial to assess the effectiveness of brief behavioral therapies (problem&#xD;
      solving therapy [PST] and Brief Behavioral Therapy for Insomnia [BBTI]) to prevent depression&#xD;
      in seniors receiving aging services.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The research will determine (i) if a course of problem solving therapy (PST) and Brief&#xD;
      Behavioral Therapy for Insomnia (BBTI), with boosters, reduces incidence of major depressive&#xD;
      episodes over 12 months relative to usual care, and (ii) the extent to which behavioral&#xD;
      therapies achieve these effects through enhancement of protective factors, such as greater&#xD;
      self-efficacy, better targeting of services to address needs, and greater control over home&#xD;
      environments.&#xD;
&#xD;
      Periodic blood draws will be used to assess biosignatures of depression. Guiding our&#xD;
      investigations of pharmacogenetics, inflammation, and proteomics are synergistic interactions&#xD;
      among the serotonergic system, the HPA axis, systemic inflammation, growth factors such as&#xD;
      brain derived neuro-trophic factor (BDNF), psychosocial stressors, and vascular co-morbidity.&#xD;
      Genetic variation in vasopressin receptors, potentially involved in both cardiovascular risk&#xD;
      and social attachment, is also associated with recurrence of depression. Similarly, genetic&#xD;
      variation in inflammation may influence antidepressant response and medical co-morbidity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major depressive disorder</measure>
    <time_frame>12 months</time_frame>
    <description>Patient Health Questionnaire score &gt; 9 with confirming diagnostic interview</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Generalized anxiety disorder</measure>
    <time_frame>12 months</time_frame>
    <description>Generalized anxiety disorder score &gt;=10, and meets criteria for SCID or PRIME-MD diagnosis</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">104</enrollment>
  <condition>Major Depression</condition>
  <condition>Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>Problem solving therapy (PST)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6-8 sessions of PST, with booster, delivered over 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual agency care, monitored for mental health services</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Problem-Solving Therapy</intervention_name>
    <description>6-8 sessions over 8 weeks, with booster</description>
    <arm_group_label>Problem solving therapy (PST)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age =&gt; 60 years&#xD;
&#xD;
          -  Modified Mini Mental State (3MS) Examination =&gt;80&#xD;
&#xD;
          -  Receiving aging services or difficulty with 1+ ADL/IADL&#xD;
&#xD;
          -  PHQ-9 score &gt; 0 and &lt;= 9 (and question 1 or 2 is &gt;0)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Major depressive episode or anxiety disorder within 12 mo&#xD;
&#xD;
          -  Ever diagnosed with bipolar disorder or schizophrenia&#xD;
&#xD;
          -  Drug or alcohol use disorder within the past 12 months&#xD;
&#xD;
          -  Currently taking antidepressants&#xD;
&#xD;
          -  Currently taking antianxiety med &gt;4x/week for past 4 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven M Albert, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15261</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>van't Veer-Tazelaar PJ, van Marwijk HW, van Oppen P, van Hout HP, van der Horst HE, Cuijpers P, Smit F, Beekman AT. Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial. Arch Gen Psychiatry. 2009 Mar;66(3):297-304. doi: 10.1001/archgenpsychiatry.2008.555.</citation>
    <PMID>19255379</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <study_first_submitted>March 27, 2012</study_first_submitted>
  <study_first_submitted_qc>March 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2012</study_first_posted>
  <last_update_submitted>December 11, 2016</last_update_submitted>
  <last_update_submitted_qc>December 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Steven M. Albert</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Depression</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Geriatric mental health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

